共 10 条
- [1] Romerius P(2009)Hypogonadism risk in men treated for childhood cancer J. Clin. Endocrinol. Metab. 94 4180-4186
- [2] Greenfield DM(2007)Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study J. Clin. Endocrinol. Metab. 92 3476-3482
- [3] Bremner WJ(1983)Loss of circadian rhythmicity in blood testosterone levels with aging in normal men J. Clin. Endocrinol. Metab. 56 1278-1281
- [4] Vitiello MV(1988)Neuroendocrine-gonadal axis in men: frequent sampling of, LH, FSH, and testosterone Am. J. Physiol. 254 E658-E666
- [5] Prinz PN(2000)Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men J. Clin. Endocrinol. Metab. 85 4500-4510
- [6] Spratt DI(2001)Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy Clin. Endocrinol. (Oxf.) 55 315-324
- [7] Swerdloff RS(2006)Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline J. Clin. Endocrinol. Metab. 91 1995-2010
- [8] Howell SJ(2007)Prevalence of symptomatic androgen deficiency J. Clin. Endocrinol. Metab. 92 4241-4247
- [9] Bhasin S(undefined)undefined undefined undefined undefined-undefined
- [10] Araujo AB(undefined)undefined undefined undefined undefined-undefined